These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 27125672)

  • 1. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
    Dayton TL; Gocheva V; Miller KM; Israelsen WJ; Bhutkar A; Clish CB; Davidson SM; Luengo A; Bronson RT; Jacks T; Vander Heiden MG
    Genes Dev; 2016 May; 30(9):1020-33. PubMed ID: 27125672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
    Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
    Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PKM2 on global metabolic changes and prognosis in hepatocellular carcinoma: from gene expression to drug discovery.
    Lv WW; Liu D; Liu XC; Feng TN; Li L; Qian BY; Li WX
    BMC Cancer; 2018 Nov; 18(1):1150. PubMed ID: 30463528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
    Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
    PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.
    Morita M; Sato T; Nomura M; Sakamoto Y; Inoue Y; Tanaka R; Ito S; Kurosawa K; Yamaguchi K; Sugiura Y; Takizaki H; Yamashita Y; Katakura R; Sato I; Kawai M; Okada Y; Watanabe H; Kondoh G; Matsumoto S; Kishimoto A; Obata M; Matsumoto M; Fukuhara T; Motohashi H; Suematsu M; Komatsu M; Nakayama KI; Watanabe T; Soga T; Shima H; Maemondo M; Tanuma N
    Cancer Cell; 2018 Mar; 33(3):355-367.e7. PubMed ID: 29533781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ-Specific MicroRNAs (
    Taniguchi K; Sugito N; Shinohara H; Kuranaga Y; Inomata Y; Komura K; Uchiyama K; Akao Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary-phytochemical mediated reversion of cancer-specific splicing inhibits Warburg effect in head and neck cancer.
    Yadav S; Bhagat SD; Gupta A; Samaiya A; Srivastava A; Shukla S
    BMC Cancer; 2019 Nov; 19(1):1031. PubMed ID: 31675998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKM2, cancer metabolism, and the road ahead.
    Dayton TL; Jacks T; Vander Heiden MG
    EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.
    Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Pyruvate Kinase M2 in Tumor Tissues Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Zhao R; Li L; Yang J; Niu Q; Wang H; Qin X; Zhu N; Shi A
    Pathol Oncol Res; 2020 Apr; 26(2):853-860. PubMed ID: 30852741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma.
    Chen Z; Lu X; Wang Z; Jin G; Wang Q; Chen D; Chen T; Li J; Fan J; Cong W; Gao Q; He X
    Oncotarget; 2015 Feb; 6(4):2538-48. PubMed ID: 25576919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
    Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
    J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
    Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
    Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic signature genes associated with susceptibility to pyruvate kinase, muscle type 2 gene ablation in cancer cells.
    Jung Y; Jang YJ; Kang MH; Park YS; Oh SJ; Lee DC; Xie Z; Yoo HS; Park KC; Yeom YI
    Mol Cells; 2013 Apr; 35(4):335-41. PubMed ID: 23515579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,3'4,4',5-Pentachlorobiphenyl induces hepatocellular carcinoma cell proliferation through pyruvate kinase M2-dependent glycolysis.
    Liang W; Zhang Y; Song L; Li Z
    Toxicol Lett; 2019 Oct; 313():108-119. PubMed ID: 31251971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.